BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36905333)

  • 1. The inaccuracies of gastric adenocarcinoma clinical staging and its predictive factors.
    Janczewski LM; Shah D; Wells A; Bentrem DJ; Abad JD; Chawla A
    J Surg Oncol; 2023 Jun; 127(7):1116-1124. PubMed ID: 36905333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inaccurate Clinical Stage Is Common for Gastric Adenocarcinoma and Is Associated with Undertreatment and Worse Outcomes.
    Ju MR; Karalis JD; Blackwell JM; Mansour JC; Polanco PM; Augustine M; Yopp AC; Zeh HJ; Wang SC; Porembka MR
    Ann Surg Oncol; 2021 May; 28(5):2831-2843. PubMed ID: 33389294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors predicting survival in patients with proximal gastric carcinoma involving the esophagus.
    Zhang YF; Shi J; Yu HP; Feng AN; Fan XS; Lauwers GY; Mashimo H; Gold JS; Chen G; Huang Q
    World J Gastroenterol; 2012 Jul; 18(27):3602-9. PubMed ID: 22826627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of Clinical Staging and Outcome With Primary Resection for Local-Regionally Limited Esophageal Adenocarcinoma.
    Worrell SG; Alicuben ET; Oh DS; Hagen JA; DeMeester SR
    Ann Surg; 2018 Mar; 267(3):484-488. PubMed ID: 28151801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma.
    Barbetta A; Schlottmann F; Nobel T; Sewell DB; Hsu M; Tan KS; Gerdes H; Shah P; Bains MS; Bott M; Isbell JM; Jones DR; Molena D
    Ann Thorac Surg; 2018 Jul; 106(1):172-177. PubMed ID: 29627387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Understaging, Treatment Response, and Survival Among Esophageal Adenocarcinoma Patients.
    da Costa WL; Gu X; Farjah F; Groth SS; Burt BM; Ripley RT; Massarweh NN
    J Surg Res; 2022 Nov; 279():256-264. PubMed ID: 35797753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
    Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
    Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
    Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
    Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Discordance of Clinical and Pathologic Staging in Locally Advanced Gastric Adenocarcinoma.
    Papageorge MV; de Geus SWL; Zheng J; Woods AP; Ng SC; Cassidy MR; McAneny D; Tseng JF; Sachs TE
    J Gastrointest Surg; 2021 Jun; 25(6):1363-1369. PubMed ID: 33846934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatment.
    Sisic L; Blank S; Nienhüser H; Dorr S; Haag GM; Jäger D; Bruckner T; Müller-Stich BP; Ott K; Büchler MW; Ulrich A; Schmidt T
    Eur J Surg Oncol; 2018 Oct; 44(10):1646-1656. PubMed ID: 30082176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.
    He MM; Zhang DS; Wang F; Wang ZQ; Luo HY; Ren C; Jin Y; Chen DL; Xu RH
    World J Gastroenterol; 2014 Jan; 20(1):264-73. PubMed ID: 24415881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors associated with survival in a large cohort of gastric cancer patients resected over a decade at a single Italian center: the Cremona experience.
    Ghidini M; Donida BM; Totaro L; Ratti M; Pizzo C; Benzoni I; Lomiento D; Aldighieri F; Toppo L; Ranieri V; Senti C; Tanzi G; Martinotti M; Passalacqua R; Rovatti M; Tomasello G
    Clin Transl Oncol; 2020 Jul; 22(7):1004-1012. PubMed ID: 31599376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased RhoA Activity Predicts Worse Overall Survival in Patients Undergoing Surgical Resection for Lauren Diffuse-Type Gastric Adenocarcinoma.
    Chang KK; Cho SJ; Yoon C; Lee JH; Park DJ; Yoon SS
    Ann Surg Oncol; 2016 Dec; 23(13):4238-4246. PubMed ID: 27364501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the 8th UICC staging system for esophageal and gastric cancers in Siewert type II junctional adenocarcinomas.
    Karstens KF; Ghadban T; Sawez S; Konczalla L; Woestemeier A; Bachmann K; Uzunoglu FG; Tachezy M; Vettorazzi E; Izbicki JR; Reeh M
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):638-643. PubMed ID: 31879051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy.
    Tian S; Jiang R; Madden NA; Ferris MJ; Buchwald ZS; Xu KM; Cardona K; Maithel SK; McDonald MW; Lin JY; Curran WJ; El-Rayes BF; Behera M; Patel PR
    Cancer; 2020 Jan; 126(1):37-45. PubMed ID: 31532544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery.
    Posteraro B; Persiani R; Dall'Armi V; Biondi A; Arzani D; Sicoli F; Bonassi S; D'Ugo D; Ricciardi W; Boccia S
    Eur J Surg Oncol; 2014 Mar; 40(3):345-51. PubMed ID: 24268760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer?
    Biondi A; D'Ugo D; Cananzi FC; Papa V; Borasi A; Sicoli F; Degiuli M; Doglietto G; Persiani R
    Eur J Surg Oncol; 2015 Jun; 41(6):779-86. PubMed ID: 25899981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of complication grade on survival following curative gastrectomy for carcinoma.
    Jiang N; Deng JY; Ding XW; Zhang L; Liu HG; Liang YX; Liang H
    World J Gastroenterol; 2014 Jul; 20(25):8244-52. PubMed ID: 25009399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with early recurrence after curative surgery for gastric cancer.
    Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
    World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.